✦ LIBER ✦

Early treatment of juvenile migraine reduces disability with disease modification implications

✍ Scribed by James A. Charles

Publisher: Springer
Year: 2007
Tongue: English
Weight: 33 KB
Volume: 8
Category: Article
ISSN: 1129-2369
DOI: 10.1007/s10194-007-0376-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Favorable outcome of early treatment of

Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification

✍ James A. Charles; B. L. Peterlin; Alan M. Rapoport; Steven L. Linder; Marielle A 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 174 KB

Reduced disability at five years with ea

Reduced disability at five years with early treatment of inflammatory polyarthritis: Results from a large observational cohort, using propensity models to adjust for disease severity

✍ Nicola J. Wiles; Mark Lunt; Elizabeth M. Barrett; Marwan Bukhari; Alan J. Silman 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 3 views

Review of donepezil, rivastigmine, galan

Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population

✍ V. P. Prasher 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Abstract The management of dementia in Alzheimer's disease has dramatically changed since the development of anti‐dementia drugs. However, there is limited information available regarding the bio‐medical aspects of the differing drugs; particularly relating to adults with intellectual disability

Impact of initial aggressive drug treatm

Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: A five-year randomized followup trial

✍ Kari Puolakka; Hannu Kautiainen; Timo Möttönen; Pekka Hannonen; Markku Korpela; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## Abstract ## Objective To compare the efficacy of therapy with a combination of disease‐modifying antirheumatic drugs (DMARDs) versus therapy with a single DMARD in the prevention of work disability in patients with early rheumatoid arthritis (RA). ## Methods In the Finnish Rheumatoid Arthriti